Skip to main content
. 2019 Feb 22;40(4):521–528. doi: 10.1093/carcin/bgz029

Table 2.

Associations between the top three representative SNPs and pancreatic cancer risk in the combined data set of PanScan and PanC4 studies

Genotype PanScan + PanC4 OR (95% CI)a P a
Case (%) Control (%)
rs3818626 T>C
TT 2402 (28.4) 2182 (31.5) 1.00
TC 4247 (50.2) 3427 (49.4) 1.13 (1.05–1.21) 0.001
CC 1808 (21.4) 1323 (19.1) 1.24 (1.13–1.36) <0.001
Trend test <0.001
Dominant model
TT 2402 (28.4) 2182 (31.5) 1.00
TC+CC 6055 (71.6) 4750 (68.5) 1.16 (1.08–1.24) <0.001
rs79447092 T>A
TT 7944 (95.2) 6421 (94.0) 1.00
TA 394 (4.7) 395 (5.8) 0.80 (0.69–0.93) 0.003
AA 4 (0.1) 12 (0.2) 0.29 (0.09–0.90) 0.032
Trend test <0.001
Dominant model
TT 7944 (95.2) 6421 (94.0) 1.00
TA+AA 398 (4.8) 407 (6.0) 0.79 (0.68–0.91) 0.001
rs9895829 A>G
AA 7675 (90.6) 6153 (88.6) 1.00
AG 775 (9.2) 769 (11.1) 0.81 (0.73–0.90) <0.001
GG 17 (0.2) 20 (0.3) 0.62 (0.32–1.19) 0.149
Trend test <0.001
Dominant model
AA 7675 (90.6) 6153 (88.6) 1.00
AG+GG 792 (9.4) 789 (11.4) 0.81 (0.73–0.90) <0.001

aAdjusted for age, sex and data source.